2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
| Consideration of a Targeted Cytomegalovirus Screening for Infants who Fail Newborn Hearing Screening.
Consideration of a Targeted Cytomegalovirus Screening for Infants who Fail Newborn Hearing Screening.
It has been estimated that 15-20% of cases of bilateral moderate to profound sensorineural hearing loss in children are due to congenital cytomegalovirus (cCMV) infection1. Due to the asymptomatic nature of cytomegalovirus infection in both pregnant women and affected infants at birth, cCMV is often not identified early, and necessary medical interventions are not instituted until after sequelae are present. The association between cCMV and permanent hearing loss in children has initiated legislation in some states mandating 1) maternal and provider education about cCMV infection 2) targeted cCMV screening following a failed newborn hearing screening (NBHS) or 3) both education and targeted cCMV screening following a failed NBHS. To assess the impact of this legislation, literature and available data from states and countries which have implemented targeted cCMV screening will be compared to available data from states which do not mandate a cCMV screening following a failed NBHS to determine the rate of infants identified with cCMV secondary to a failed NBHS. In addition, information about the efficacy of early intervention for both the treatment of cCMV infection and the management of permanent hearing loss will be investigated, with the aim being to determine the overall merits of cCMV screening following a failed NBHS.
1.Grosse, S.D., Ross, D. S., & Dollard, S. C. (2007). Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. Journal of Clinical Virology, 41(2). doi: 10.1016/j.jcv.2007.09.004
- Assessment of the efficacy of targeted cCMV screening at accurately identifying cCMV secondary to congenital hearing loss.
- Comparison of the overall effectiveness of mandated cCMV screening programs following a failed newborn hearing screening.
- Further investigation of outcomes and implementation of early interventions for cCMV and SNHL.
Presentation:
3353554_14974GraceHaines-Gallagher.pdf
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Grace Haines-Gallagher
(Primary Presenter,Author), Purdue University , ghainesg@purdue.edu;
Grace Haines-Gallagher is a third year doctor of audiology student at Purdue University. She attended Indiana University for her Bachelor of Arts in Speech and Hearing Sciences with a minor in Psychology.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -
Lata Krishnan
(Co-Author), Purdue University, krishnal@purdue.edu;
Lata A. Krishnan, PhD, CCC-A has been in the Speech, Language, and Hearing Sciences (SLHS) department at Purdue University since 1998. She received her BSc. in Speech and Hearing from the University of Mysore, India in 1984, her MS in Audiology from Rush University in 1987 and her PhD in Hearing Science from Purdue University in 2008. Dr. Krishnan's experience includes more than 25 years of clinical supervision of graduate students in two university clinics, and development of two study abroad programs: SLHS in Zambia, the first study abroad program in the SLHS department, and more recently SLHS in India. Her current responsibilities include clinical supervision of graduate students, classroom teaching of undergraduate and graduate students and leading the new SLHS in India study abroad program.
Dr. Krishnan's professional interests are in the areas of diagnostic audiology, auditory physiology and electrophysiology, and pediatric assessment and intervention.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -